# Back pain doctor Phoenix: common questions answered *Back Soreness Questions | Back Pain Doctor Phoenix* > Plain answers about prepared blood procedures, disc soreness, costs, and back pain treatment Phoenix choices. Begin with the question closest to your concern. The answers can help you prepare for a visit. They can't replace an exam. Get prompt care for bladder changes, numb inner thighs, or fast-growing weakness. ## Sources 1. The FDA states verbatim that stem cell products, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products have NOT been 'approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' No stem cell product is approved in the United States for any orthopedic use: the only ones with FDA approval at all are blood-forming cells derived from umbilical cord blood, approved solely for disorders of blood production, and there are currently no FDA-approved exosome products. U.S. Food and Drug Administration — [Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.](https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes). *FDA.gov*, 2025. 2. The only double-blind randomised trial of intradiscal PRP for discogenic low back pain enrolled 47 participants (29 PRP, 18 control) and reported statistically significant improvements in pain, function and satisfaction over EIGHT WEEKS compared with a contrast-agent control. It is a small, single-centre trial, the control group was offered crossover to PRP at 8 weeks, and no disc infection, neurological injury or progressive herniation was reported. The authors themselves call the results promising and say further studies are needed to define who responds. Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, et al. — [Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study.](https://pubmed.ncbi.nlm.nih.gov/26314234/). *PM&R*, 2016. DOI: 10.1016/j.pmrj.2015.08.010. 3. A 2026 double-blind randomised superiority trial of 76 patients with facet joint syndrome found PRP was NOT superior to corticosteroid: at six months only 6 PRP patients and 5 corticosteroid patients had reached the 50% pain-improvement endpoint, and there were no statistically significant differences in pain at 3, 6 or 12 months. The authors conclude the results 'do not support the use of PRP injections for facet joint syndrome.' Geoffroy M, Beissat M, Kanagaratnam L, Ackah Miezan S, Salmon JH — [Platelet-rich plasma versus corticosteroids in facet joint syndrome: A controlled, randomized, double-blind study.](https://pubmed.ncbi.nlm.nih.gov/41183587/). *Joint Bone Spine*, 2026. DOI: 10.1016/j.jbspin.2025.106001. 4. A double-blinded randomised trial at two university spine centres, using stringent inclusion criteria (>80% relief on a diagnostic block) and fluoroscopic guidance, compared sacroiliac joint PRP with sacroiliac steroid in 26 patients. Both groups improved, but the STEROID group reported lower pain and had significantly more responders (>=50% improvement) at one and three months than the PRP group. This is the best-designed sacroiliac comparison available and it favours the cheap conventional option. Chen AS, Solberg J, Smith C, et al. — [Intra-Articular Platelet Rich Plasma vs Corticosteroid Injections for Sacroiliac Joint Pain: A Double-Blinded, Randomized Clinical Trial.](https://pubmed.ncbi.nlm.nih.gov/34850180/). *Pain Medicine*, 2022. DOI: 10.1093/pm/pnab332. 5. An open-blinded-endpoint randomised trial of 40 patients compared ultrasound-guided sacroiliac PRP with methylprednisolone and found the OPPOSITE: pain was significantly lower in the PRP group at six weeks and three months, with efficacy of 90% in the PRP arm versus 25% in the steroid arm at three months. It was not double-blinded and used ultrasound rather than fluoroscopic guidance, which is exactly why it and the double-blinded trial that contradicts it must be read together. Singla V, Batra YK, Bharti N, Goni VG, Marwaha N — [Steroid vs. Platelet-Rich Plasma in Ultrasound-Guided Sacroiliac Joint Injection for Chronic Low Back Pain.](https://pubmed.ncbi.nlm.nih.gov/27677100/). *Pain Practice*, 2017. DOI: 10.1111/papr.12526. 6. A 2026 meta-analysis with trial sequential analysis pooled 10 randomised and quasi-randomised trials (392 patients) comparing PRP with corticosteroid for facet and sacroiliac joint pain. PRP did not beat steroid at one month, but did at three months (MD -1.32) and six months (MD -1.70), while disability showed no significant difference at either time point. The authors state plainly that 'current evidence remains inconclusive' and that the certainty is limited. Alatefi D, Alkabazi M, Alanzi A, et al. — [Platelet-Rich Plasma versus Corticosteroid Injections for Facet and Sacroiliac Joint Pain: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.](https://pubmed.ncbi.nlm.nih.gov/42296329/). *Pain Medicine*, 2026. DOI: 10.1093/pm/pnag072. 7. A ten-year matched-cohort study found that simply PUNCTURING a lumbar disc with a small-gauge needle for diagnostic discography accelerated its degeneration: 35% of punctured discs progressed versus 14% of matched control discs, there were 55 new disc herniations versus 22, and new herniations occurred disproportionately on the side of the annular puncture, with significantly greater loss of disc height and signal. Every intradiscal injection - PRP, bone marrow concentrate or cells - requires that same puncture. Carragee EJ, Don AS, Hurwitz EL, et al. — [2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study.](https://pubmed.ncbi.nlm.nih.gov/19755936/). *Spine*, 2009. DOI: 10.1097/BRS.0b013e3181ab5432. 8. A review of the risks of intradiscal orthobiologic injections found the published safety base is small - 136 patients across all MSC intradiscal studies with two serious adverse events (one infection, one progressive disc herniation), and 194 patients across PRP intradiscal studies with one serious adverse event - and adds three previously unpublished serious adverse events from one clinic, including a confirmed Cutibacterium acnes disc infection and two presumed cases of discitis, all three after bone marrow concentrate. The authors recommend gentamicin and a two-needle technique to mitigate spondylodiscitis risk. Jerome MA, Lutz C, Lutz GE — [Risks of Intradiscal Orthobiologic Injections: A Review of the Literature and Case Series Presentation.](https://pubmed.ncbi.nlm.nih.gov/34376494/). *International Journal of Spine Surgery*, 2021. DOI: 10.14444/8053. 9. The 2025 ASIPP regenerative-therapy guideline for chronic low back pain - written by the specialty society that performs these procedures - grades the evidence as Level III (fair) for intradiscal PRP, Level III (fair) for intradiscal bone marrow concentrate, Level III (fair) for epidural PRP, Level IV (limited) for facet joint PRP and MSC injections, Level IV (limited) for sacroiliac joint PRP, and very low for functional-spine-unit injections. All 19 recommendations are consensus-based rather than evidence-driven, the panel names the scarcity of high-quality studies as the primary limitation, and it states that most of these therapies are not covered by commercial insurance. Manchikanti L, Navani R, Navani A, et al. — [Comprehensive Evidence-Based Guidelines for Regenerative Therapies in the Management of Chronic Low Back Pain: 2025 Update from the American Society Of Interventional Pain Physicians (ASIPP).](https://pubmed.ncbi.nlm.nih.gov/41481869/). *Pain Physician*, 2025. 10. CMS covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and then only inside an approved coverage-with-evidence-development clinical study. There is no national Medicare coverage for PRP in low back pain of any origin, and commercial plans generally follow with musculoskeletal PRP non-coverage policies. Centers for Medicare & Medicaid Services — [Autologous Platelet-rich Plasma - Coverage with Evidence Development.](https://www.cms.gov/medicare/coverage/evidence/plasma). *CMS.gov*, 2025. ## What is PRP, and can it help back soreness? First, blood is drawn and spun. The spinning gathers platelets, tiny blood cells that help stop bleeding, into plasma, the pale liquid part of blood. Doctors call the prepared mix PRP. Back studies have mixed results, so it doesn't help everyone. Ask which back area would receive it and why. ## Can PRP heal a bulging disc? Research hasn't shown that prepared blood rebuilds a bulging disc. Your soreness can improve while the disc looks unchanged on a scan. Those are different results. Ask whether the aim is easier movement, better sleep, or less soreness. Don't accept a promise that the disc will grow back. ## What does stem cell therapy for back pain cost? The amount can differ by the procedure and follow-up. Insurance may not cover regenerative care, meaning treatment made from your own blood. Get a written total before agreeing. It needs to include the visit, procedure, and return care. Ask whether another session brings another charge. ## What can help facet joint soreness? Facet joints are the small joints behind your back bones. Heat, easy movement, and guided exercise may help. A clinician may discuss a procedure if soreness continues. Research on prepared blood for these joints isn't settled. Ask what the exam found before choosing care for that joint. ## What's next when facet care hasn't helped? First, review where your soreness starts. Care that didn't help may have reached the wrong body part. Ask whether your usual ache changed during any numbing test. Then discuss safe movement and other possible causes. Don't move to another procedure until the reason is clear. ## What should I ask a Phoenix clinic first? Ask which back area seems sore and what the exam found. If your back hasn't settled, QC Kinetix can discuss regenerative, non-surgical options made from your blood. A clinician examines you and gives care, and the clinic calls that person a medical provider. Ask where the blood goes, what recovery involves, and what you'll pay. ## Discuss the sore area before choosing care Bring notes about your soreness, medicines, and any scan. The clinician can compare those details with your exam. You'll be able to ask which back area may be causing trouble. If your back hasn't settled, QC Kinetix can discuss non-surgical regenerative treatment options made from prepared blood. Its medical providers can explain where that material goes and what recovery involves. Call (602) 837-PAIN to arrange a visit. Schedule a free consultation: --- Help for a sore back and the next decision. Learn what can ease back soreness, when to get care, and what non-surgical choices you can discuss in Phoenix. Plain help for understanding back soreness and your choices. Back Pain Phoenix is operated by the same owners who run the QC Kinetix Phoenix-area clinics, and those owners may benefit when this publication sends a reader to their clinic team. Copyright 2026 Phoenix Backpath. Educational material for preparing questions, not a diagnosis or personal treatment plan.